RDSMY
Royal DSM NV ADROTCQX
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Thu, Nov. 3, 9:22 AM
    | Thu, Nov. 3, 9:22 AM
  • Tue, Aug. 2, 9:22 AM
    | Tue, Aug. 2, 9:22 AM
  • Tue, Apr. 26, 9:06 AM
    • Royal DSM NV ADR (OTCQX:RDSMY): Q1 EPS of €0.60
    • Revenue of €1.91B (+1.1% Y/Y)
    | Tue, Apr. 26, 9:06 AM
  • May 3, 2012, 10:50 AM
    Kensey Nash (KNSY) surges 32% to $38.33, nearing the $38.50/share that Royal DSM (RDSMY.PK) is paying for the medical-device company.
    | May 3, 2012, 10:50 AM
  • May 3, 2012, 10:14 AM
    Kensey Nash (KNSY): FQ3 EPS of $0.34 misses by $0.01. Revenue of $69.3M (+19.4% Y/Y) in-line. (PR)
    | May 3, 2012, 10:14 AM
  • May 3, 2012, 9:00 AM

    Premarket gainers: KNSY +32%. CXW +10%. APKT +7%. ONNN +6%. CLUU +5%. WFM +4%. ARNA +4%. RIG +4%. VIA +3%. TDC +3%. AMT +3%. JRCC +3%. COCO +3%. BUD +3%.
    Losers: GMCR -41%. WTW -15%. ATML -8%. NMM -6%. JDSU -4%. TRS -5%. ARO -4%. HT -4%. M -3%. MGM -3%.

    | May 3, 2012, 9:00 AM
  • May 3, 2012, 2:28 AM

    Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be bought by Royal DSM (RDSMY.PK) for $38.50/share, more than a 30% premium to Kensey Nash's close yesterday. (PR)

    | May 3, 2012, 2:28 AM
  • Mar. 19, 2012, 2:13 PM

    Kensey Nash (KNSY +24%) jumps after saying it's reached a settlement with St. Jude Medical (STJ -0.6%), resolving its dispute regarding vascular closure device licenses and related claims. Under the deal, St. Jude will pay Kensey $39 million over several quarters.

    | Mar. 19, 2012, 2:13 PM
  • Feb. 2, 2012, 7:33 AM
    Kensey Nash (KNSY): FQ2 EPS of $0.51 beats by $0.05. Revenue of $23M (+32.2% Y/Y) misses by $0.5M. (PR)
    | Feb. 2, 2012, 7:33 AM
  • Dec. 16, 2011, 2:38 PM
    Kensey Nash (KNSY -22%) tanks hard, hitting fresh year lows after saying it is lowering its guidance due to a dispute with St Jude Medical (STJ -1.8%) over royalty rates.
    | Dec. 16, 2011, 2:38 PM
  • Dec. 16, 2011, 7:58 AM

    Kensey Nash (KNSY) agrees to enter mediation with St. Jude Medical (STJ) over royalty payments it says it's owed tied to the Angio-Seal vascular closure device. Shares halted premarket.

    | Dec. 16, 2011, 7:58 AM
  • Dec. 29, 2009, 5:20 PM

    The quants at Credit Suisse identify 24 Buffett-esque stocks: AFAM, AMGN, APEI, ATRI, AZZ, BKE, BUCY, BYI, CHD, EME, ENSG, JNJ, JOSB, KNSY, LINC, NPK, PETS, POWL, ROST, SCL, TJX, TNDM, VAR, WMS.

    | Dec. 29, 2009, 5:20 PM | 2 Comments